Dyadic International Inc
NASDAQ:DYAI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.985
2.27
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DYAI stock under the Base Case scenario is 2.08 USD. Compared to the current market price of 1.91 USD, Dyadic International Inc is Undervalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dyadic International Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DYAI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Dyadic International Inc
Balance Sheet Decomposition
Dyadic International Inc
Current Assets | 10.7m |
Cash & Short-Term Investments | 9.9m |
Receivables | 393.8k |
Other Current Assets | 374.2k |
Non-Current Assets | 115.3k |
PP&E | 104.9k |
Other Non-Current Assets | 10.3k |
Current Liabilities | 2.1m |
Accrued Liabilities | 1m |
Other Current Liabilities | 1.1m |
Non-Current Liabilities | 5.3m |
Long-Term Debt | 5.3m |
Other Non-Current Liabilities | 48.1k |
Earnings Waterfall
Dyadic International Inc
Revenue
|
3.4m
USD
|
Cost of Revenue
|
-1.2m
USD
|
Gross Profit
|
2.2m
USD
|
Operating Expenses
|
-8.7m
USD
|
Operating Income
|
-6.5m
USD
|
Other Expenses
|
195.1k
USD
|
Net Income
|
-6.3m
USD
|
Free Cash Flow Analysis
Dyadic International Inc
USD | |
Free Cash Flow | USD |
DYAI Profitability Score
Profitability Due Diligence
Dyadic International Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Dyadic International Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
DYAI Solvency Score
Solvency Due Diligence
Dyadic International Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
Dyadic International Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DYAI Price Targets Summary
Dyadic International Inc
According to Wall Street analysts, the average 1-year price target for DYAI is 7.65 USD with a low forecast of 6.06 USD and a high forecast of 9.45 USD.
Dividends
Current shareholder yield for DYAI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
DYAI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. The company is headquartered in Jupiter, Florida and currently employs 7 full-time employees. The company went IPO on 2004-11-05. The firm is focused on developing C1 platform for use in human and animal pharmaceutical applications across the world. The C1 platform technology is based on the Myceliopthora thermophila fungus, which the Company named it as C1. The C1 gene expression platform is used in the discovery, development and manufacturing of biologic medicines and vaccines. The C1 technology is a fungal expression system for gene discovery, development, and production of enzymes and other proteins. The C1 technology is commercially available solutions to uptake genes and develop industrial processes to produce volumes of enzymes and other protein products. The firm is also working on COVID-19 related vaccine and antibody opportunities, including COVID-19 vaccine candidate, DYAI-100.
Contact
IPO
Employees
Officers
The intrinsic value of one DYAI stock under the Base Case scenario is 2.08 USD.
Compared to the current market price of 1.91 USD, Dyadic International Inc is Undervalued by 8%.